[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Betahistine.]
[N06AF04, tranylcypromine, The metabolism of Betahistine can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The therapeutic efficacy of Betahistine can be decreased when used in combination with Trazodone.]
[R06AD01, trimeprazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Alimemazine.]
[N06AA06, trimipramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Trimipramine.]
[R06AC04, tripelennamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Tripelennamine.]
[R06AX07, triprolidine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Triprolidine.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Betahistine.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Betahistine can be decreased when used in combination with Zuclopenthixol.]
[N05AE04, ziprasidone, The therapeutic efficacy of Betahistine can be decreased when used in combination with Ziprasidone.]
[N04BD02, rasagiline, The metabolism of Betahistine can be decreased when combined with Rasagiline.]
[R06AC06, thonzylamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Thonzylamine.]
[N04AC01, benztropine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzatropine.]
[C01CA27, droxidopa, The therapeutic efficacy of Droxidopa can be decreased when used in combination with Betahistine.]
[A03BA03, hyoscyamine, Betahistine may increase the anticholinergic activities of Hyoscyamine.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Betahistine.]
[N06AX11, mirtazapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Mirtazapine.]
[R06AB01, brompheniramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dexbrompheniramine.]
[R06AX09, azatadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Azelastine.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Betahistine.]
[J01XX08, linezolid, The metabolism of Betahistine can be decreased when combined with Linezolid.]
[N04BD03, safinamide, The metabolism of Betahistine can be decreased when combined with Safinamide.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Betahistine.]
[N06AA15, butriptyline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Butriptyline.]
[R06AX18, acrivastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Acrivastine.]
[R06AA08, carbinoxamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Carbinoxamine.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be decreased when used in combination with Betahistine.]
[S01GX12, cetirizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Cetirizine.]
[R06AC03, chloropyramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chloropyramine.]
[R06AA06, chlorphenoxamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorphenoxamine.]
[R05DB10, chlophedianol, The therapeutic efficacy of Betahistine can be decreased when used in combination with Clofedanol.]
[N07XX11, pitolisant, The therapeutic efficacy of Betahistine can be decreased when used in combination with Pitolisant.]
[R06AB06, dexbrompheniramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dexbrompheniramine.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dexchlorpheniramine.]
[R06AA07, diphenylpyraline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Diphenylpyraline.]
[R06AE04, chlorcyclizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorcyclizine.]
[R06AX22, ebastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Ebastine.]
[R06AB04, chlorpheniramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorpheniramine.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorpromazine.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorprothixene.]
[R03CC15, formoterol, The therapeutic efficacy of Formoterol can be decreased when used in combination with Betahistine.]
[A02BA01, cimetidine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Cimetidine.]
[N07CA02, cinnarizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Cinnarizine.]
[R06AA04, clemastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Clemastine.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Betahistine.]
[N05AH02, clozapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Clozapine.]
[R06AX27, desloratadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Desloratadine.]
[R06AD09, isothipendyl, The therapeutic efficacy of Betahistine can be decreased when used in combination with Isothipendyl.]
[S01GX06, emedastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Emedastine.]
[S01GX02, levocabastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocabastine.]
[R06AX13, loratadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Loratadine.]
[R06AD07, mequitazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Mequitazine.]
[R06AD04, methdilazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Methdilazine.]
[R03CB02, methoxyphenamine, Methoxyphenamine may decrease the sedative and stimulatory activities of Betahistine.]
[R06AE03, cyclizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyclizine.]
[N06AX07, minaprine, The metabolism of Betahistine can be decreased when combined with Minaprine.]
[N06AG02, moclobemide, The metabolism of Betahistine can be decreased when combined with Moclobemide.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyproheptadine.]
[N06AA01, desipramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Desipramine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the sedative and stimulatory activities of Betahistine.]
[R06AX04, phenindamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Phenindamine.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Betahistine.]
[A08AA03, diethylpropion, Diethylpropion may decrease the sedative and stimulatory activities of Betahistine.]
[R06AA11, dimenhydrinate, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dimenhydrinate.]
[R06AB03, dimethindene, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dimetindene.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Betahistine.]
[R06AA02, diphenhydramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Diphenhydramine.]
[N05AX08, risperidone, The therapeutic efficacy of Betahistine can be decreased when used in combination with Risperidone.]
[R06AE09, levocetirizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocetirizine.]
[R03AC12, salmeterol, The therapeutic efficacy of Salmeterol can be decreased when used in combination with Betahistine.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be decreased when used in combination with Betahistine.]
[N06AA16, dothiepin, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dosulepin.]
[N06AA12, doxepin, The therapeutic efficacy of Betahistine can be decreased when used in combination with Doxepin.]
[R06AA09, doxylamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Doxylamine.]
[N06AG03, toloxatone, The metabolism of Betahistine can be decreased when combined with Toloxatone.]
[R06AX21, tritoqualine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Tritoqualine.]
[S01GX10, epinastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Epinastine.]
[S01EA01, epinephrine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Betahistine.]
[C01CA15, gepefrine, Gepefrine may decrease the sedative and stimulatory activities of Betahistine.]
[A02BA04, nizatidine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Nizatidine.]
[R06AX11, astemizole, The therapeutic efficacy of Betahistine can be decreased when used in combination with Astemizole.]
[R06AX12, terfenadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Terfenadine.]
[A02BA03, famotidine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Famotidine.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Betahistine.]
[R03CC02, albuterol, The therapeutic efficacy of Salbutamol can be decreased when used in combination with Betahistine.]
[N07CA03, flunarizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Flunarizine.]
[G01AX06, furazolidone, The metabolism of Betahistine can be decreased when combined with Furazolidone.]
[N02CX05, fonazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Dimetotiazine.]
[N05AH04, quetiapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Quetiapine.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Betahistine.]
[R06AE06, oxatomide, The therapeutic efficacy of Betahistine can be decreased when used in combination with Oxatomide.]
[N05BB01, hydroxyzine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Hydroxyzine.]
[N06AA02, imipramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Imipramine.]
[R06AE01, buclizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Buclizine.]
[N06AF05, iproniazid, The metabolism of Betahistine can be decreased when combined with Iproniazid.]
[N06AF01, isocarboxazid, The metabolism of Betahistine can be decreased when combined with Isocarboxazid.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Betahistine.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Betahistine.]
[C01DA14, isosorbide mononitrate, Betahistine may increase the vasodilatory activities of Isosorbide mononitrate.]
[N05AH03, olanzapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Olanzapine.]
[R06AX25, mizolastine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Mizolastine.]
[S01GX08, ketotifen, The therapeutic efficacy of Betahistine can be decreased when used in combination with Ketotifen.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Betahistine.]
[N06AA21, maprotiline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline.]
[R06AE05, meclizine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Meclizine.]
[C01CA11, mephentermine, Mephentermine may decrease the sedative and stimulatory activities of Betahistine.]
[N06BA03, methamphetamine, Metamfetamine may decrease the sedative and stimulatory activities of Betahistine.]
[A03AB07, methantheline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Methantheline.]
[R06AC05, methapyrilene, The therapeutic efficacy of Betahistine can be decreased when used in combination with Methapyrilene.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Methotrimeprazine.]
[V04CG05, methylene blue, The metabolism of Betahistine can be decreased when combined with Methylene blue.]
[N06AX03, mianserin, The therapeutic efficacy of Betahistine can be decreased when used in combination with Mianserin.]
[N06BA12, lisdexamfetamine, Lisdexamfetamine may decrease the sedative and stimulatory activities of Betahistine.]
[N06AA09, amitriptyline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Amitriptyline.]
[N06AA17, amoxapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Amoxapine.]
[N06BA01, amphetamine, Amphetamine may decrease the sedative and stimulatory activities of Betahistine.]
[N05AX14, iloperidone, The therapeutic efficacy of Betahistine can be decreased when used in combination with Iloperidone.]
[N06AF02, nialamide, The metabolism of Betahistine can be decreased when combined with Nialamide.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Betahistine.]
[N06AA10, nortriptyline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Nortriptyline.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Betahistine.]
[N05AH05, asenapine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Asenapine.]
[C02KC01, pargyline, The metabolism of Betahistine can be decreased when combined with Pargyline.]
[N06AF03, phenelzine, The metabolism of Betahistine can be decreased when combined with Phenelzine.]
[R06AB05, pheniramine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Pheniramine.]
[A08AA01, phentermine, Phentermine may decrease the sedative and stimulatory activities of Betahistine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Betahistine.]
[N02CX01, pizotyline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Pizotifen.]
[R06AX05, antazoline, The therapeutic efficacy of Betahistine can be decreased when used in combination with Antazoline.]
[S01HA05, procaine, The metabolism of Betahistine can be decreased when combined with Procaine.]
[L01XB01, procarbazine, The metabolism of Betahistine can be decreased when combined with Procarbazine.]
[N05AA03, promazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Promethazine.]
[R06AX26, fexofenadine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Fexofenadine.]
[N05CM06, propiomazine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Propiomazine.]
[R01BA02, pseudoephedrine, Pseudoephedrine may decrease the sedative and stimulatory activities of Betahistine.]
[N05AX12, aripiprazole, The therapeutic efficacy of Betahistine can be decreased when used in combination with Aripiprazole.]
[R06AC01, pyrilamine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Mepyramine.]
[A02BA02, ranitidine, The therapeutic efficacy of Betahistine can be decreased when used in combination with Ranitidine.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Betahistine.]
[N04BD01, selegiline, The metabolism of Betahistine can be decreased when combined with Selegiline.]
